We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck Antitrust Scheme Didn’t Work, UK Says, Ending Probe

Law360 (March 14, 2019, 9:21 PM EDT) -- UK antitrust authorities announced Thursday that they’d dropped an investigation into Merck’s discounting practices for its arthritis medicine Remicade not because it wasn’t anticompetitive but because the discounts didn’t create the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.